FI110097B - 5-(3-imidazo[4,5-b]pyridin-1-yl-3-fenyl-akryloyloxi)-cyklohexankarboxylsyraderivat, användning och läkemedel innehållande av föreningar - Google Patents

5-(3-imidazo[4,5-b]pyridin-1-yl-3-fenyl-akryloyloxi)-cyklohexankarboxylsyraderivat, användning och läkemedel innehållande av föreningar Download PDF

Info

Publication number
FI110097B
FI110097B FI952203A FI952203A FI110097B FI 110097 B FI110097 B FI 110097B FI 952203 A FI952203 A FI 952203A FI 952203 A FI952203 A FI 952203A FI 110097 B FI110097 B FI 110097B
Authority
FI
Finland
Prior art keywords
phenyl
eller
diabetes
imidazo
pyridin
Prior art date
Application number
FI952203A
Other languages
English (en)
Finnish (fi)
Other versions
FI952203A (sv
FI952203A0 (sv
Inventor
Horst Hemmerle
Gerrit Schubert
Andreas Herling
Hans-Joerg Burger
Suad Efendic
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI952203A0 publication Critical patent/FI952203A0/sv
Publication of FI952203A publication Critical patent/FI952203A/sv
Application granted granted Critical
Publication of FI110097B publication Critical patent/FI110097B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI952203A 1994-05-10 1995-05-08 5-(3-imidazo[4,5-b]pyridin-1-yl-3-fenyl-akryloyloxi)-cyklohexankarboxylsyraderivat, användning och läkemedel innehållande av föreningar FI110097B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4416433 1994-05-10
DE4416433A DE4416433A1 (de) 1994-05-10 1994-05-10 Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten

Publications (3)

Publication Number Publication Date
FI952203A0 FI952203A0 (sv) 1995-05-08
FI952203A FI952203A (sv) 1995-11-11
FI110097B true FI110097B (sv) 2002-11-29

Family

ID=6517746

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952203A FI110097B (sv) 1994-05-10 1995-05-08 5-(3-imidazo[4,5-b]pyridin-1-yl-3-fenyl-akryloyloxi)-cyklohexankarboxylsyraderivat, användning och läkemedel innehållande av föreningar

Country Status (23)

Country Link
US (1) US5739147A (sv)
EP (1) EP0682024B1 (sv)
JP (1) JP3790564B2 (sv)
KR (1) KR100355690B1 (sv)
CN (1) CN1043643C (sv)
AT (1) ATE187454T1 (sv)
AU (1) AU683148B2 (sv)
CA (1) CA2149007C (sv)
CZ (1) CZ288443B6 (sv)
DE (2) DE4416433A1 (sv)
DK (1) DK0682024T3 (sv)
ES (1) ES2141276T3 (sv)
FI (1) FI110097B (sv)
GR (1) GR3032519T3 (sv)
HK (1) HK1011989A1 (sv)
HU (1) HU220865B1 (sv)
NO (1) NO304314B1 (sv)
NZ (1) NZ272082A (sv)
PL (1) PL180074B1 (sv)
RU (1) RU2140416C1 (sv)
TW (1) TW421648B (sv)
UA (1) UA41340C2 (sv)
ZA (1) ZA953726B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
ES2433476T3 (es) 2000-01-21 2013-12-11 Novartis Ag Combinaciones que contienen inhibidores de la dipeptidilpeptidasa-IV y agentes 5 antidiabéticos
EP1385549A2 (en) * 2001-03-12 2004-02-04 Novartis AG Combination of nateglinide or repaglinide with at least one further antidiabetic compound
PL1931350T5 (pl) 2005-09-14 2021-11-15 Takeda Pharmaceutical Company Limited Podanie inhibitorów dipeptydylo-peptydazy
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
PT2531501E (pt) 2010-02-03 2014-02-17 Takeda Pharmaceutical Inibidores da cinase de regulação do sinal de apoptose 1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243016A (ja) * 1984-05-17 1985-12-03 Tsumura Juntendo Inc 抗インフルエンザウイルス剤
TW399041B (en) * 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases
TW255880B (sv) * 1992-09-09 1995-09-01 Hoechst Ag
DE4408082A1 (de) * 1994-03-10 1995-09-14 Hoechst Ag Substituierte Propan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE4413402A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Herstellung von Zwischenprodukten für die Synthese von Glucose-6-Phosphatase-Inhibitoren sowie neue Zwischenprodukte

Also Published As

Publication number Publication date
PL180074B1 (pl) 2000-12-29
AU683148B2 (en) 1997-10-30
RU2140416C1 (ru) 1999-10-27
HK1011989A1 (en) 1999-07-23
EP0682024A1 (de) 1995-11-15
RU95107147A (ru) 1997-03-20
HUT71797A (en) 1996-02-28
NZ272082A (en) 1996-09-25
HU220865B1 (en) 2002-06-29
ATE187454T1 (de) 1999-12-15
PL308521A1 (en) 1995-11-13
TW421648B (en) 2001-02-11
CZ288443B6 (en) 2001-06-13
CZ119595A3 (en) 1995-12-13
ZA953726B (en) 1996-01-11
CN1118782A (zh) 1996-03-20
NO951820L (no) 1995-11-13
AU1792395A (en) 1995-11-16
FI952203A (sv) 1995-11-11
NO951820D0 (no) 1995-05-09
ES2141276T3 (es) 2000-03-16
NO304314B1 (no) 1998-11-30
CN1043643C (zh) 1999-06-16
DE4416433A1 (de) 1995-11-16
DE59507361D1 (de) 2000-01-13
CA2149007C (en) 2005-07-26
GR3032519T3 (en) 2000-05-31
US5739147A (en) 1998-04-14
KR950032191A (ko) 1995-12-20
EP0682024B1 (de) 1999-12-08
FI952203A0 (sv) 1995-05-08
KR100355690B1 (ko) 2002-12-26
UA41340C2 (uk) 2001-09-17
JPH07330767A (ja) 1995-12-19
CA2149007A1 (en) 1995-11-11
DK0682024T3 (da) 2000-05-22
JP3790564B2 (ja) 2006-06-28

Similar Documents

Publication Publication Date Title
US4996206A (en) N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
US5681959A (en) Chemical synthesis of azaindoles
FI103409B (sv) Förfarande för framställning av farmaceutiskt användbara benzimidazold erivat
FI85482B (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva 9-/3-(4-guanidinofenyl) propylamino/oktahydro-10 oxo-6h-pyridazo/1,2-a//1,2/diazepin-1-karboxylsyraderivat.
FR2563521A1 (fr) Derives de la 1,4-dihydro-4-oxonaphtyridine et leurs sels, procede pour leur production et agents antibacteriens les contenant
FR2598709A1 (fr) Derives de l'acide quinoleinecarboxylique
MXPA04000159A (es) Compuestos heterociclicos 8/17 y usos de los mismos como inhibidores de ligasa d-alanil-d-alanina.
JPH01500834A (ja) アザインドール及びインドリジン誘導体、その製造方法及び薬剤としてのその用途
US4831030A (en) Diphenylpyridine compounds, processes for the preparation thereof and composition comprising the same
JP2002526542A (ja) Ｘａ因子阻害作用を有するイミダゾール［４，５−Ｃ−］−ピリジン−４−オン誘導体
FI110097B (sv) 5-(3-imidazo[4,5-b]pyridin-1-yl-3-fenyl-akryloyloxi)-cyklohexankarboxylsyraderivat, användning och läkemedel innehållande av föreningar
FI88295C (sv) Förfarande för framställning av nya, terapeutiskt användbara 5-karbony lamino-4-hydroxi-N-hexanamidderivat
EP0388298B1 (fr) Dérivés d'acides pyridone carboxyliques azétidinyl substitues, leur préparation et leur application en tant que médicaments
HUT64759A (en) Method for producing tetrazolyl-(phenoxy-and phenoxy-alkyl-)-pyridinyl-pyridazines
FR2933701A1 (fr) Derives anticancereux, leur preparation et leur application en therapeutique
PT88432B (pt) Processo para a preparacao de acidos 4-oxo-3-quinolinocarboxilicos uteis como agentes anti-bacterianos
EP0966466A1 (en) PYRROLO 3,2-c]QUINOLINE DERIVATIVES CONTAINING HALOALKOXY GROUP AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
JP2008528667A (ja) 化合物
US4060527A (en) Pyrido[2,3-c]-acridine-1-hydroxy-2-carboxylic acid derivatives
ZA200505077B (en) Atropisomers of 3-substituted-4-arylquinolin-2-onederivatives
Jung et al. SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF NEW CEPHALOSPORINS WITH AMINOIMIDAZOLES AT C-7 EFFECT OF THE pKa OF THE C-7 AMINOIMIDAZOLE ON ANTIBACTERIAL SPECTRUM AND β-LACTAMASE STABILITY
BG107219A (bg) Терапевтично приложими нови соли на сск инхибитори, методи за тяхното получаване и фармацевтични състави, които ги съдържат
FI97386C (sv) Förfarande för framställning av terapeutiskt användbara aminosubstituerade tvärbundna azabicykliska kinolonkarboxylsyror och estrar av dessa
HU203727B (en) Process for producing anellated azepinone derivatives and pharmaceutical compositions containing them as active components
EP0145304B1 (en) Tetrahydro-beta-carboline derivatives and process for the preparation thereof

Legal Events

Date Code Title Description
MA Patent expired